United States · FDA National Drug Code directory

ciprofloxacin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-0408_7d2d3be8-5b23-4e66-be62-cfedd2dbccd7
Product NDC
71335-0408
Form
TABLET
Composition / generic term
ciprofloxacin
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20040910
Source listing expiry
20261231

Source-listed ingredients

  • CIPROFLOXACIN HYDROCHLORIDE — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 7 TABLET in 1 BOTTLE (71335-0408-0) · 71335-0408-0
  • 20 TABLET in 1 BOTTLE (71335-0408-1) · 71335-0408-1
  • 10 TABLET in 1 BOTTLE (71335-0408-2) · 71335-0408-2
  • 14 TABLET in 1 BOTTLE (71335-0408-3) · 71335-0408-3
  • 6 TABLET in 1 BOTTLE (71335-0408-4) · 71335-0408-4
  • 30 TABLET in 1 BOTTLE (71335-0408-5) · 71335-0408-5
  • 60 TABLET in 1 BOTTLE (71335-0408-6) · 71335-0408-6
  • 12 TABLET in 1 BOTTLE (71335-0408-7) · 71335-0408-7
  • 40 TABLET in 1 BOTTLE (71335-0408-8) · 71335-0408-8
  • 90 TABLET in 1 BOTTLE (71335-0408-9) · 71335-0408-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →